<DOC>
	<DOC>NCT01100476</DOC>
	<brief_summary>The Mynx Vascular Closure Device (Mynx M5) is a sponge-like material used to close the hole in the artery after patients undergo a diagnostic endovascular procedures</brief_summary>
	<brief_title>Mynx M5 One Hour Ambulation Study</brief_title>
	<detailed_description>Key Inclusion: 1. Patients &gt;18 yrs of age 2. Patient underwent a percutaneous diagnostic procedure utilizing a 5F procedural sheath via the common femoral artery. 3. Patient is able to ambulate (routinely walk 6 meters or 20 feet without assistance for any reason) as assessed by investigator.</detailed_description>
	<criteria>Patient is &gt; 18 years of age Patient underwent a percutaneous diagnostic procedure utilizing a 5F procedural sheath in the common femoral artery Patient has been informed and understands the nature of the study and provides written INformed COnsent approved by the appropriate Institutional Review Board (IRB) prior to enrollment Patient is able to ambulate (routinely walk 6 meters or 20 feet without assistance for any reason) as assessed by the investigator PreProcedure Exclusion Criteria Patient had a prior surgical procedure, PTA, stent placement, or vascular graft in the common femoral artery Patient has a bleeding disorder such as thrombocytopenia Patient has uncontrolled hypertension Patient is morbidly obese (BMI &gt;40 kg/m2 Patient is pregnant or lactating Patient has a documented INR &gt;1.5 or patients currently receiving glycoprotein IIb/IIIa platelet inhibitor Patient has a known severe allergy to contrast medium Patient has a known allergy to PEG Patient is unable to ambulate at one hour secondary to a comorbid condition Patient is know to require an extended hospitalization or rehospitalization (e.g.patient is undergoing coronary artery bypass graft (CABG) surgery) or patient is scheduled to have a CABG surgery &lt;30 days following the procedure IntraProcedure Exclusion Criteria Common femoral artery is &lt;5mm in diameter Patient with clinically significant peripheral vascular disease in the vicinity of the puncture Puncture site is located above the most inferior border of the inferior epigastric artery (IEA) and/or above the inguinal ligament based upon bony landmarks Patient has a posterior puncture or multiple punctures in an attempt to gain access Patient has an ipsilateral venous sheath Patient has a preexisting arterial bleed/extravasation identified on preprocedure femoral arteriogram, hematoma, pseudoaneurysm or arteriovenous fistula present prior to sheath removal Patient has intraprocedural bleeding around the access site prior to sheath removal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Closure Device</keyword>
	<keyword>endovascular procedures</keyword>
	<keyword>sealing femoral arterial access</keyword>
	<keyword>Mynx M5</keyword>
</DOC>